Show simple item record

dc.contributor.authorShenoy, Savitha
dc.date.accessioned2023-06-15T15:01:29Z
dc.date.available2023-06-15T15:01:29Z
dc.date.issued2023-04-12
dc.identifier.citationMushtaq, T., Ali, S. R., Boulos, N., Boyle, R., Cheetham, T., Davies, J. H., Elder, C. J., Gan, H. W., Hindmarsh, P. C., Katugampola, H., Krone, N., Salomon Estebanez, M., Shenoy, S., Tollerfield, S., Wong, S. C., Regan, F., & Developed by the Paediatric Adrenal Insufficiency Group on behalf of the British Society for Paediatric Endocrinology and Diabetes (BSPED) (2023). Emergency and perioperative management of adrenal insufficiency in children and young people: British Society for Paediatric Endocrinology and Diabetes consensus guidance. Archives of disease in childhood, archdischild-2022-325156. Advance online publication. https://doi.org/10.1136/archdischild-2022-325156en_US
dc.identifier.other10.1136/archdischild-2022-325156
dc.identifier.urihttp://hdl.handle.net/20.500.12904/17204
dc.description.abstractAdrenal insufficiency (AI) is characterised by lack of cortisol production from the adrenal glands. This can be a primary adrenal disorder or secondary to adrenocorticotropic hormone deficiency or suppression from exogenous glucocorticoids. Symptoms of AI in children may initially be non-specific and include growth faltering, lethargy, poor feeding, weight loss, abdominal pain, vomiting and lingering illnesses. AI is treated with replacement doses of hydrocortisone. At times of physiological stress such as illness, trauma or surgery, there is an increased requirement for exogenous glucocorticoids, which if untreated can lead to an adrenal crisis and death. There are no unified guidelines for those <18 years old in the UK, leading to substantial variation in the management of AI. This paper sets out guidance for intercurrent illness, medical, dental and surgical procedures to allow timely and appropriate recognition and treatment of AI and adrenal crisis for children and young people.
dc.description.urihttps://adc.bmj.com/content/early/2023/04/11/archdischild-2022-325156en_US
dc.language.isoenen_US
dc.subjectEmergency serviceen_US
dc.subjectHospitalen_US
dc.subjectEndocrinologyen_US
dc.subjectPaediatricsen_US
dc.titleEmergency and perioperative management of adrenal insufficiency in children and young people: British Society for Paediatric Endocrinology and Diabetes consensus guidanceen_US
dc.typeArticleen_US
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US
rioxxterms.versionNAen_US
rioxxterms.versionofrecordhttp://dx.doi.org/10.1136/archdischild-2022-325156en_US
rioxxterms.typeJournal Article/Reviewen_US
refterms.panelUnspecifieden_US
html.description.abstractAdrenal insufficiency (AI) is characterised by lack of cortisol production from the adrenal glands. This can be a primary adrenal disorder or secondary to adrenocorticotropic hormone deficiency or suppression from exogenous glucocorticoids. Symptoms of AI in children may initially be non-specific and include growth faltering, lethargy, poor feeding, weight loss, abdominal pain, vomiting and lingering illnesses. AI is treated with replacement doses of hydrocortisone. At times of physiological stress such as illness, trauma or surgery, there is an increased requirement for exogenous glucocorticoids, which if untreated can lead to an adrenal crisis and death. There are no unified guidelines for those <18 years old in the UK, leading to substantial variation in the management of AI. This paper sets out guidance for intercurrent illness, medical, dental and surgical procedures to allow timely and appropriate recognition and treatment of AI and adrenal crisis for children and young people.en_US
rioxxterms.funder.project94a427429a5bcfef7dd04c33360d80cden_US


This item appears in the following Collection(s)

Show simple item record